Eqis Capital Management Trimmed Its Becton Dickinson & Co (BDX) Stake; Axa Lowered Alexion Pharmaceuticals (ALXN) Position By $14.42 Million

Eqis Capital Management Inc decreased Becton Dickinson & Co (BDX) stake by 48.28% reported in 2017Q3 SEC filing. Eqis Capital Management Inc sold 2,035 shares as Becton Dickinson & Co (BDX)’s stock rose 1.79%. The Eqis Capital Management Inc holds 2,180 shares with $427,000 value, down from 4,215 last quarter. Becton Dickinson & Co now has $58.98B valuation. The stock decreased 0.31% or $0.68 during the last trading session, reaching $221.4. About 1.74 million shares traded or 34.88% up from the average. Becton, Dickinson and Company (NYSE:BDX) has risen 12.32% since January 9, 2017 and is uptrending. It has underperformed by 4.38% the S&P500.

Axa decreased Alexion Pharmaceuticals Inc (ALXN) stake by 12.55% reported in 2017Q3 SEC filing. Axa sold 102,989 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 11.63%. The Axa holds 717,938 shares with $100.72 million value, down from 820,927 last quarter. Alexion Pharmaceuticals Inc now has $26.74B valuation. The stock decreased 2.52% or $3.1 during the last trading session, reaching $119.7. About 3.20 million shares traded or 45.71% up from the average. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since January 9, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Since July 31, 2017, it had 0 insider buys, and 6 sales for $2.74 million activity. Veneman Ann M had sold 700 shares worth $96,418. Wagner Heidi L had sold 120 shares worth $16,800. Another trade for 11,160 shares valued at $1.56 million was made by O’Neill Julie on Monday, August 28. The insider HANTSON LUDWIG sold 2,553 shares worth $310,521.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.20, from 1.37 in 2017Q2. It worsened, as 36 investors sold ALXN shares while 174 reduced holdings. 78 funds opened positions while 167 raised stakes. 206.89 million shares or 0.54% less from 208.01 million shares in 2017Q2 were reported. Stephens Management Grp Incorporated Limited holds 0.05% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 16,251 shares. Creative Planning has 16,131 shares. D Scott Neal holds 0.1% or 1,200 shares. Goldman Sachs Grp Inc Inc invested in 3.46M shares or 0.12% of the stock. Parkside Bank & Trust has invested 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Tealwood Asset Management Inc invested in 11,455 shares or 0.58% of the stock. Kentucky Retirement System Insur Tru Fund holds 5,938 shares or 0.15% of its portfolio. Lord Abbett Limited Co holds 213,881 shares or 0.09% of its portfolio. Stifel Corp holds 49,377 shares. The California-based California State Teachers Retirement Sys has invested 0.11% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Vident Inv Advisory Limited Liability holds 0.06% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 8,065 shares. State Treasurer State Of Michigan holds 0.42% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 367,678 shares. Honeywell owns 189,400 shares for 0.93% of their portfolio. Ww Asset reported 0.1% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Teachers Retirement System Of The State Of Kentucky reported 240,022 shares or 0.4% of all its holdings.

Among 28 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 23 have Buy rating, 0 Sell and 5 Hold. Therefore 82% are positive. Alexion Pharmaceuticals Inc. has $257 highest and $82 lowest target. $169.33’s average target is 41.46% above currents $119.7 stock price. Alexion Pharmaceuticals Inc. had 89 analyst reports since July 27, 2015 according to SRatingsIntel. As per Friday, October 28, the company rating was upgraded by FBR Capital. As per Thursday, September 15, the company rating was initiated by FBR Capital. JP Morgan upgraded the shares of ALXN in report on Tuesday, September 5 to “Overweight” rating. Suntrust Robinson initiated the shares of ALXN in report on Thursday, January 7 with “Buy” rating. UBS maintained the stock with “Buy” rating in Thursday, February 4 report. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Neutral” rating given on Friday, September 23 by Wedbush. The rating was maintained by BMO Capital Markets with “Buy” on Friday, October 20. Oppenheimer maintained the stock with “Hold” rating in Wednesday, June 14 report. The rating was downgraded by Barclays Capital on Monday, September 14 to “Equal Weight”. PiperJaffray reinitiated Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Monday, October 23 with “Overweight” rating.

Analysts await Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report earnings on February, 15. They expect $1.08 earnings per share, down 1.82% or $0.02 from last year’s $1.1 per share. ALXN’s profit will be $241.28M for 27.71 P/E if the $1.08 EPS becomes a reality. After $1.28 actual earnings per share reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -15.63% negative EPS growth.

Axa increased Ishares (ENZL) stake by 7,300 shares to 36,200 valued at $1.71 million in 2017Q3. It also upped Tesaro Inc (NASDAQ:TSRO) stake by 57,300 shares and now owns 121,449 shares. Ishares Tr (IWD) was raised too.

Eqis Capital Management Inc increased Banco Bradesco S A (NYSE:BBD) stake by 31,127 shares to 52,661 valued at $583,000 in 2017Q3. It also upped Alphabet Inc stake by 315 shares and now owns 3,496 shares. Amn Healthcare Services Inc (NYSE:AHS) was raised too.

Since August 9, 2017, it had 0 buys, and 9 insider sales for $15.96 million activity. The insider Polen Thomas E Jr sold $1.18M. 6,149 Becton, Dickinson and Company (NYSE:BDX) shares with value of $1.24 million were sold by Shabshab Nabil. 15,044 shares valued at $3.02 million were sold by COHEN GARY M on Tuesday, August 22. Strahlman Ellen R had sold 9,283 shares worth $1.84 million on Thursday, August 10. $941,254 worth of Becton, Dickinson and Company (NYSE:BDX) shares were sold by Tharby Linda M. Sichak Stephen also sold $2.36M worth of Becton, Dickinson and Company (NYSE:BDX) on Friday, September 8. Mas Ribo Alberto sold 7,463 shares worth $1.50M.

Among 18 analysts covering Becton Dickinson (NYSE:BDX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Becton Dickinson has $260.0 highest and $146 lowest target. $223.53’s average target is 0.96% above currents $221.4 stock price. Becton Dickinson had 46 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Piper Jaffray given on Tuesday, July 18. As per Monday, July 10, the company rating was maintained by RBC Capital Markets. The rating was maintained by Cowen & Co on Wednesday, December 20 with “Buy”. The rating was maintained by Argus Research with “Buy” on Wednesday, August 19. The firm has “Hold” rating given on Wednesday, January 6 by Evercore. Wells Fargo initiated Becton, Dickinson and Company (NYSE:BDX) on Friday, September 22 with “Buy” rating. On Thursday, January 5 the stock rating was downgraded by Raymond James to “Outperform”. The stock has “Hold” rating by RBC Capital Markets on Friday, September 22. The firm has “Buy” rating given on Friday, June 9 by Jefferies. The company was maintained on Tuesday, September 26 by Jefferies.

Investors sentiment decreased to 0.93 in 2017 Q3. Its down 0.25, from 1.18 in 2017Q2. It worsened, as 53 investors sold BDX shares while 344 reduced holdings. 74 funds opened positions while 297 raised stakes. 197.53 million shares or 0.90% more from 195.76 million shares in 2017Q2 were reported. The West Virginia-based Mckinley Carter Wealth Svcs has invested 0.91% in Becton, Dickinson and Company (NYSE:BDX). 1,700 are held by Bailard Incorporated. Community Tru & reported 1,050 shares. Victory Management holds 4,206 shares. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 0.19% or 105,188 shares. Moreover, St Germain D J has 1.31% invested in Becton, Dickinson and Company (NYSE:BDX). Checchi Cap Advisers Ltd Limited Liability Company invested 0.04% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). Meristem Llp has invested 0.46% in Becton, Dickinson and Company (NYSE:BDX). Monroe National Bank Trust Mi reported 400 shares. New York-based Grandfield Dodd Ltd Liability Corporation has invested 0.08% in Becton, Dickinson and Company (NYSE:BDX). Deutsche Retail Bank Ag owns 1.43M shares for 0.19% of their portfolio. Private Advisor Gru Limited Liability Company accumulated 8,108 shares. Vident Invest Advisory Ltd Limited Liability Company, Georgia-based fund reported 3,318 shares. 1,666 are owned by Winslow Evans And Crocker. Moreover, Pictet Asset Management Ltd has 0.12% invested in Becton, Dickinson and Company (NYSE:BDX) for 221,336 shares.